<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641925</url>
  </required_header>
  <id_info>
    <org_study_id>2015-07-010</org_study_id>
    <secondary_id>KSWEET-02</secondary_id>
    <nct_id>NCT02641925</nct_id>
  </id_info>
  <brief_title>Omentectomy for Metabolic Syndrome in Gastric Cancer Patients</brief_title>
  <official_title>The Effect of Visceral Fat Removal for Gastric Cancer Patients With Metabolic Syndrome, Randomized Pilot Study: Omentectomy for Metabolic Syndrome (OMS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dong-A University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many features of the metabolic syndrome are associated with insulin resistance. And,
      metabolic syndrome and insulin resistance are related to visceral obesity. Therefore, the
      investigators hypothesized that visceral fat removal (omentectomy) can make favorable results
      for the insulin resistance and metabolic syndrome. As the omentectomy is optional procedure
      during a surgery for early gastric cancer, the investigators will divide patients randomly
      into two groups, total omentectomy group and omentum preserving group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will compare the change of insulin resistance (HOMA-IR) and improvement of
      metabolic syndrome between total omentectomy and omentum preserving group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HOMA-IR change</measure>
    <time_frame>pre-operative and post-operative 12months</time_frame>
    <description>HOMA-IR change after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prevalence of metabolic syndrome</measure>
    <time_frame>pre-operative and post-operative 12months</time_frame>
    <description>check the presence of metabolic syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication</measure>
    <time_frame>within 30days</time_frame>
    <description>short-term any complication related to surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-IR change according to anastomosis type</measure>
    <time_frame>pre-operative and post-operative 12months</time_frame>
    <description>comparison between Billoth-II and Roux-en-Y</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Omentum preserving</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Omentum preserving: The minimum volume of omentum (within 3cm from gastroepiploic vessel) will be removed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total omentectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total omentectomy: Whole omentum will be removed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Omentum preserving</intervention_name>
    <description>The minimum volume of omentum (within 3cm from gastroepiploic vessel) will be removed during gastrectomy with lymph node dissection.</description>
    <arm_group_label>Omentum preserving</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total omentectomy</intervention_name>
    <description>Whole omentum will be removed during gastrectomy with lymph node dissection.</description>
    <arm_group_label>Total omentectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed adenocarcinoma in stomach

          -  Aged≥20 years and ≤80 years

          -  Scheduled as laparoscopic distal gastrectomy (cT1N0M0 or cT2N0M0)

          -  Metabolic syndrome (NCEP:ATP III (National Cholesterol Education Program and Adult
             Treatment Panel III) -harmonizing definition criteria

          -  ECOG 0 (Eastern Cooperative Oncology Group)

          -  ASA score class I-III (American Society of Anesthesiologists)

          -  patient has given their written informed consent to participate in the study

        Exclusion Criteria:

          -  Simultaneously combined resection of other organ

          -  Active other malignancy

          -  Expected to severe intra-abdominal adhesion due to previous abdominal operation
             history

          -  Uncontrolled co-morbidity

          -  Vulnerable patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korean South West East Gastric Surgery Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
    <phone>82-53-250-7322</phone>
    <email>gsman@dsmc.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <state>Jeollanam-do</state>
        <zip>519-809</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Kyu Park, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Seong Yeop Ryu, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeong Oh, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mi Ran Jung, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>602-715</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Chan Kim, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Min Chan Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Wan Ryu, MD, PhD</last_name>
      <phone>82-53-250-7322</phone>
      <email>gsman@dsmc.or.kr</email>
    </contact>
    <contact_backup>
      <last_name>In Gyu Kwon, MD</last_name>
      <phone>82-53-250-7322</phone>
      <email>surgeon@dsmc.or.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Seung Wan Ryu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>In Gyu Kwon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young Gil Son, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>An JY, Kim YM, Yun MA, Jeon BH, Noh SH. Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy. World J Gastroenterol. 2013 Dec 28;19(48):9410-7. doi: 10.3748/wjg.v19.i48.9410.</citation>
    <PMID>24409070</PMID>
  </reference>
  <reference>
    <citation>Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim ÉA, Baracat J, Geloneze B. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring). 2013 Mar;21(3):E182-9. doi: 10.1002/oby.20030.</citation>
    <PMID>23404948</PMID>
  </reference>
  <reference>
    <citation>Lottati M, Kolka CM, Stefanovski D, Kirkman EL, Bergman RN. Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring). 2009 Apr;17(4):674-80. doi: 10.1038/oby.2008.642. Epub 2009 Feb 12.</citation>
    <PMID>19214178</PMID>
  </reference>
  <reference>
    <citation>Sdralis E, Argentou M, Mead N, Kehagias I, Alexandridis T, Kalfarentzos F. A prospective randomized study comparing patients with morbid obesity submitted to sleeve gastrectomy with or without omentectomy. Obes Surg. 2013 Jul;23(7):965-71. doi: 10.1007/s11695-013-0925-z.</citation>
    <PMID>23526069</PMID>
  </reference>
  <reference>
    <citation>Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011. Review.</citation>
    <PMID>23303913</PMID>
  </reference>
  <reference>
    <citation>Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9.</citation>
    <PMID>11850750</PMID>
  </reference>
  <reference>
    <citation>Herrera MF, Pantoja JP, Velázquez-Fernández D, Cabiedes J, Aguilar-Salinas C, García-García E, Rivas A, Villeda C, Hernández-Ramírez DF, Dávila A, Zaraín A. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial. Diabetes Care. 2010 Jul;33(7):1413-8. doi: 10.2337/dc09-1833.</citation>
    <PMID>20587720</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2015</study_first_submitted>
  <study_first_submitted_qc>December 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Keimyung University Dongsan Medical Center</investigator_affiliation>
    <investigator_full_name>Seung Wan Ryu</investigator_full_name>
    <investigator_title>Director of Gastrointesinal surgery, associate professor</investigator_title>
  </responsible_party>
  <keyword>Metabolic syndrome</keyword>
  <keyword>gastric cancer</keyword>
  <keyword>omentectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

